Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Invest in Legion M Stock and Disrupt Hollywood Forever

If you decide to invest in Legion M stock, you'll help democratize Hollywood by allowing stakeholders a voice in the creative and production process.

9 Companies to Invest In as U.S.-China Relations Deteriorate

The devastation of the coronavirus was the last straw for the Trump administration, prompting an aggressive approach to U.S.-China relations. Here are some of the top companies to invest in to account for this foreign policy shift.

For Delta Air Lines, It’s Not About the Middle Seats

With higher travel demand and lower coronavirus cases, the nearer-term narrative has improved for DAL stock. However, you should check the economic forecast before booking a flight.

9 Stocks to Buy to Profit off the Baby Boomer Generation

Baby boomers have a reputation of being old and therefore irrelevant. However, this powerful and influential generation can spark huge demand for many stocks to buy.

Inovio Pharmaceuticals is Still Very Relevant Despite Speculative Nature

With more competition in the vaccine race, INO stock lost much of its sheen. But don’t rule out Inovio Pharmaceuticals because it has critical advantages that others lack.